“You could have the cure for cancer, but if you can’t execute, it doesn’t matter.” ...

Georgia Witchel's Mantis Biotech makes Parva, consumer software that reads how a person types and clicks to flag cognitive ...

VERAXA Biotech (NASDAQ: VRXA) announced the appointment of Christoph Erkel, Ph.D., as chief scientific officer, ...

Fortress Biotech transformed its balance sheet by selling a Priority Review Voucher for $205 million, netting $159 million.

Puma Biotechnology will host a conference call beginning at 1:30 p.m. PT on Aug. 6, following release of its earnings results for 2Q-2026.

Nautilus Biotechnology is now prioritizing targeted proteoform assays after broadscale testing failed to support its prior ...

Austin, Texas, August 6th, 2026, FinanceWireThe company has advanced its VXA-222 bispecific antibody-drug conjugate ...

Rare-disease families can now invest in Mahzi Therapeutics' gene therapy, giving patients a financial stake in developing treatments for their own communities ...

The Board of the Company notes the announcement by Worldwide Healthcare Trust PLC regarding changes to its portfolio management arrangements and confirms that there is no change to the Company's ...

VERAXA Biotech (NASDAQ: VRXA) announced an expansion of its intellectual property portfolio, filing new patent ...

The puppies represent a key first step towards addressing canine allergenicity and mark potentially a significant advance in ...

Ying Huang, Ph.D., steps down as Chief Executive Officer and member of the Board of Directors; will remain as an advisor through August to ...